Healthcare Focus Montserrat: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Focus Montserrat.

Press releases published on November 12, 2026

3 hours ago

IMUNON Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

3 hours ago

Aktis Oncology Reports Third-Quarter Financial Results and Highlights Clinical Trial Progress

Indeterminate GlobeNewswire

3 hours ago

Kyverna Therapeutics Announces Completion of BLA Submission for Miv-cel in Stiff Person Syndrome and Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

3 hours ago

Monopar Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

3 hours ago

Randomized Study of Non-Invasive Autonomic Neuromodulation for Long COVID Published Online in Neuromodulation

Indeterminate GlobeNewswire

3 hours ago

Vivani Medical Announces Positive Top-Line Results from SLIM-1™, a First in Human Phase 1 Trial of NPM-139 (semaglutide implant) and Wegovy (weekly semaglutide injections) in Obese and Overweight Subjects

Indeterminate GlobeNewswire

3 hours ago

Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference 2026 in London

Indeterminate GlobeNewswire

3 hours ago

R1 Takes Aim at Healthcare’s Fragmented Revenue Cycle with Six Connected AI Solutions

Indeterminate GlobeNewswire

4 hours ago

Biolojic Design Receives U.S. FDA Clearance of Investigational New Drug (IND) Application for BD200, the First Multibody to Enter Clinical Trials

Indeterminate GlobeNewswire

4 hours ago

123Dentist CEO Jeff Leger and family establish fund at Dalhousie University’s Faculty of Dentistry to advance research into the connection between oral health and overall health

Indeterminate GlobeNewswire

4 hours ago

Jeff Leger, président-directeur général de 123Dentiste, et sa famille créent un fonds à la Faculté de médecine dentaire de l’Université Dalhousie pour mieux comprendre le lien entre santé buccodentaire et santé globale

Indeterminate GlobeNewswire

4 hours ago

Sagimet Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

4 hours ago

Profusa Announces Progress Towards Satisfying the Conditions to Close of the Option Agreement with G3

Indeterminate GlobeNewswire

4 hours ago

Aclaris Therapeutics to Participate in the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

4 hours ago

Taysha Gene Therapies Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

4 hours ago

Altimmune Announces Third Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire

4 hours ago

Cerenome to Review REYOBIQ ReSPECT-LM Data Presented at SNO Conference and Provide CNSide Commercial Update on November 16

Indeterminate GlobeNewswire

4 hours ago

Immuneering Announces New Potentially Registrational Phase 2 Trial Evaluating Atebimetinib with Chemotherapy in Anaplastic Thyroid Cancer

Indeterminate GlobeNewswire

4 hours ago

Avicanna Reports Positive Adjusted EBITDA for Q3 2026 and Provides Corporate Update

Indeterminate GlobeNewswire

4 hours ago

Cormedix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire